Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151

Jessica Tilghman, Paula Schiapparelli, Bachuchu Lal, Mingyao Ying, Alfredo Quinones-Hinojosa, Shuli Xia, John Laterra

Research output: Contribution to journalArticle

Abstract

Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing therapeutic strategies for targeting GSC-dependent oncogenic mechanisms. Using GBM-derived neurospheres, we identified the cell surface tetraspanin family member CD151 as a novel regulator of glioma cell stemness, GSC self-renewal capacity, migration, and tumor growth. CD151 was found to be overexpressed in GBM tumors and GBM neurospheres enriched in GSCs. Silencing CD151 inhibited neurosphere forming capacity, neurosphere cell proliferation, and migration and attenuated the expression of markers and transcriptional drivers of the GSC phenotype. Conversely, forced CD151 expression promoted neurosphere self-renewal, cell migration, and expression of stemness-associated transcription factors. CD151 was found to complex with integrins α3, α6, and β1 in neurosphere cells, and blocking CD151 interactions with integrins α3 and α6 inhibited AKT phosphorylation, a downstream effector of integrin signaling, and impaired sphere formation and neurosphere cell migration. Additionally, targeting CD151 in vivo inhibited the growth of GBM neurosphere-derived xenografts. These findings identify CD151 and its interactions with integrins α3 and α6 as potential therapeutic targets for inhibiting stemness-driving mechanisms and stem cell populations in GBM.

Original languageEnglish (US)
Pages (from-to)185-198
Number of pages14
JournalNeoplasia
Volume18
Issue number3
DOIs
StatePublished - 2016

Fingerprint

Glioblastoma
Integrins
Stem Cells
Neoplasms
Cell Movement
Neoplastic Stem Cells
Drug Resistance
Heterografts
Glioma
Transcription Factors
Phosphorylation
Cell Proliferation
Phenotype
Recurrence

ASJC Scopus subject areas

  • Cancer Research

Cite this

Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. / Tilghman, Jessica; Schiapparelli, Paula; Lal, Bachuchu; Ying, Mingyao; Quinones-Hinojosa, Alfredo; Xia, Shuli; Laterra, John.

In: Neoplasia, Vol. 18, No. 3, 2016, p. 185-198.

Research output: Contribution to journalArticle

Tilghman, J, Schiapparelli, P, Lal, B, Ying, M, Quinones-Hinojosa, A, Xia, S & Laterra, J 2016, 'Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151' Neoplasia, vol 18, no. 3, pp. 185-198. DOI: 10.1016/j.neo.2016.02.003
Tilghman J, Schiapparelli P, Lal B, Ying M, Quinones-Hinojosa A, Xia S et al. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. Neoplasia. 2016;18(3):185-198. Available from, DOI: 10.1016/j.neo.2016.02.003

Tilghman, Jessica; Schiapparelli, Paula; Lal, Bachuchu; Ying, Mingyao; Quinones-Hinojosa, Alfredo; Xia, Shuli; Laterra, John / Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.

In: Neoplasia, Vol. 18, No. 3, 2016, p. 185-198.

Research output: Contribution to journalArticle

@article{f04170979fbf4ee1ba99f831ad9cd8ab,
title = "Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151",
abstract = "Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing therapeutic strategies for targeting GSC-dependent oncogenic mechanisms. Using GBM-derived neurospheres, we identified the cell surface tetraspanin family member CD151 as a novel regulator of glioma cell stemness, GSC self-renewal capacity, migration, and tumor growth. CD151 was found to be overexpressed in GBM tumors and GBM neurospheres enriched in GSCs. Silencing CD151 inhibited neurosphere forming capacity, neurosphere cell proliferation, and migration and attenuated the expression of markers and transcriptional drivers of the GSC phenotype. Conversely, forced CD151 expression promoted neurosphere self-renewal, cell migration, and expression of stemness-associated transcription factors. CD151 was found to complex with integrins α3, α6, and β1 in neurosphere cells, and blocking CD151 interactions with integrins α3 and α6 inhibited AKT phosphorylation, a downstream effector of integrin signaling, and impaired sphere formation and neurosphere cell migration. Additionally, targeting CD151 in vivo inhibited the growth of GBM neurosphere-derived xenografts. These findings identify CD151 and its interactions with integrins α3 and α6 as potential therapeutic targets for inhibiting stemness-driving mechanisms and stem cell populations in GBM.",
author = "Jessica Tilghman and Paula Schiapparelli and Bachuchu Lal and Mingyao Ying and Alfredo Quinones-Hinojosa and Shuli Xia and John Laterra",
year = "2016",
doi = "10.1016/j.neo.2016.02.003",
volume = "18",
pages = "185--198",
journal = "Neoplasia",
issn = "1522-8002",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151

AU - Tilghman,Jessica

AU - Schiapparelli,Paula

AU - Lal,Bachuchu

AU - Ying,Mingyao

AU - Quinones-Hinojosa,Alfredo

AU - Xia,Shuli

AU - Laterra,John

PY - 2016

Y1 - 2016

N2 - Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing therapeutic strategies for targeting GSC-dependent oncogenic mechanisms. Using GBM-derived neurospheres, we identified the cell surface tetraspanin family member CD151 as a novel regulator of glioma cell stemness, GSC self-renewal capacity, migration, and tumor growth. CD151 was found to be overexpressed in GBM tumors and GBM neurospheres enriched in GSCs. Silencing CD151 inhibited neurosphere forming capacity, neurosphere cell proliferation, and migration and attenuated the expression of markers and transcriptional drivers of the GSC phenotype. Conversely, forced CD151 expression promoted neurosphere self-renewal, cell migration, and expression of stemness-associated transcription factors. CD151 was found to complex with integrins α3, α6, and β1 in neurosphere cells, and blocking CD151 interactions with integrins α3 and α6 inhibited AKT phosphorylation, a downstream effector of integrin signaling, and impaired sphere formation and neurosphere cell migration. Additionally, targeting CD151 in vivo inhibited the growth of GBM neurosphere-derived xenografts. These findings identify CD151 and its interactions with integrins α3 and α6 as potential therapeutic targets for inhibiting stemness-driving mechanisms and stem cell populations in GBM.

AB - Glioblastoma (GBM) stem cells (GSCs) represent tumor-propagating cells with stem-like characteristics (stemness) that contribute disproportionately to GBM drug resistance and tumor recurrence. Understanding the mechanisms supporting GSC stemness is important for developing therapeutic strategies for targeting GSC-dependent oncogenic mechanisms. Using GBM-derived neurospheres, we identified the cell surface tetraspanin family member CD151 as a novel regulator of glioma cell stemness, GSC self-renewal capacity, migration, and tumor growth. CD151 was found to be overexpressed in GBM tumors and GBM neurospheres enriched in GSCs. Silencing CD151 inhibited neurosphere forming capacity, neurosphere cell proliferation, and migration and attenuated the expression of markers and transcriptional drivers of the GSC phenotype. Conversely, forced CD151 expression promoted neurosphere self-renewal, cell migration, and expression of stemness-associated transcription factors. CD151 was found to complex with integrins α3, α6, and β1 in neurosphere cells, and blocking CD151 interactions with integrins α3 and α6 inhibited AKT phosphorylation, a downstream effector of integrin signaling, and impaired sphere formation and neurosphere cell migration. Additionally, targeting CD151 in vivo inhibited the growth of GBM neurosphere-derived xenografts. These findings identify CD151 and its interactions with integrins α3 and α6 as potential therapeutic targets for inhibiting stemness-driving mechanisms and stem cell populations in GBM.

UR - http://www.scopus.com/inward/record.url?scp=84963958993&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84963958993&partnerID=8YFLogxK

U2 - 10.1016/j.neo.2016.02.003

DO - 10.1016/j.neo.2016.02.003

M3 - Article

VL - 18

SP - 185

EP - 198

JO - Neoplasia

T2 - Neoplasia

JF - Neoplasia

SN - 1522-8002

IS - 3

ER -